Sources | Names Used |
---|---|
CTRPv2 | YL54 |
PharmacoGx | YL54 |
Database | Identifier |
---|---|
Smiles: | CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CCNC(C)=O)C(=O)N[C@]1(C)CCCC=C/CCC[C@@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-385J1.3 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | CD38 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |
mRNA | C11orf16 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | UNC50 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
mRNA | C2CD4B | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | TGIF2LX | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | MSC | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | SPATA31D1 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | DUX4 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | CD72 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |